Crossmark

Review of the Food and Drug Administration’s Center for Drug Evaluation and Research Program for New Molecular Entities: Trends and Regulatory Requirements in Mid-Cycle Communications

Crossref DOI link: https://doi.org/10.1007/s43441-023-00511-7

Published Online: 2023-04-04

Published Print: 2023-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hoffman, Richard D. https://orcid.org/0000-0002-6709-684X
Beattie, Scott D.

Camp, Jennifer Riddle

Fuhs, Jillian Venci
License Information

Text and Data Mining valid from 2023-04-04

Version of Record valid from 2023-04-04
More Information

Article History

Received: 8 December 2022

Accepted: 7 March 2023

First Online: 4 April 2023

Declarations

:

: Richard Hoffman, Scott Beattie, Jennifer Camp, and Jillian Fuhs are employees of- and have stock in Eli Lilly & Co.

Document is current

Any future updates will be listed below